NDC directory

Pentoxifylline

Advagen Pharma Ltd., · TABLET

72888-268NDA AUTHORIZED GENERICBlood Viscosity Reducer [EPC]
Product NDC
72888-268
Generic name
Pentoxifylline
Labeler name
Advagen Pharma Ltd.,
Brand name
Pentoxifylline
Finished
true
Listing expiration date
20271231
Marketing category
NDA AUTHORIZED GENERIC
Dosage form
TABLET
SPL ID
5b32a4ae-24c9-c81c-e063-6394a90a867d
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261001
Product ID
72888-268_5b32a4ae-24c9-c81c-e063-6394a90a867d
Application number
NDA018631
Brand name base
Pentoxifylline
Active ingredients
  1. Name
    PENTOXIFYLLINE
    Strength
    400 mg/1
Packaging
  1. Package NDC
    72888-268-01
    Description
    30 TABLET in 1 BOTTLE (72888-268-01)
    Marketing start date
    20261001
    Sample
    false
  2. Package NDC
    72888-268-02
    Description
    100 TABLET in 1 BOTTLE (72888-268-02)
    Marketing start date
    20261001
    Sample
    false
  3. Package NDC
    72888-268-03
    Description
    500 TABLET in 1 BOTTLE (72888-268-03)
    Marketing start date
    20261001
    Sample
    false
Route
ORAL
Pharm class
Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.